Lifeward Ltd. - LFWD Real Price to Acquire Entire Company

LFWD (Lifeward Ltd.) - company brandmark

Revenue growth for ReWalk Robotics Ltd. (LFWD), a developer of exoskeletons, is being driven by the expansion of Medicare programs. However, business success depends on the willingness of clinics to implement robotics and new insurance reimbursement rules. This chart illustrates an Enterprise Value of 18.07, while operating losses render cash flows unstable, as reflected in the daily price action.

LFWD (ReWalk Robotics Ltd) Total Company Value history from 11/23/2025 to 10/27/2026

Financial and market metric breakdowns for ReWalk Robotics Ltd. (LFWD)

- price and consensus price forecast:
Quote Chart ReWalk Robotics|LFWD - Consensus Target
- market capitalization data:
Market Valuation Lifeward|LFWD - Enterprise Value
- book capitalization data:
Equity per Share Lifeward|LFWD - Company Book Value|Market Capitalization to Book Value rewalk.com|LFWD - Aggregate Company Assets
- debt and liquidity data:
Aggregate Debt to Equity ReWalk Robotics Ltd.|LFWD - Long-Term Debt to Capital|Current Liabilities to Capital rewalk.com|LFWD - Company Aggregate Debts|Debt to Book Value Lifeward
Fundamental company valuation:LFWD (ReWalk Robotics)
Original product of ReWalk Robotics Ltd

Systemic inertia in medical centers, driven by the costs of training personnel to operate ReWalk Robotics Ltd. (LFWD) exoskeletons, generates a steady cash flow from services. This market capitalization plus net debt digitizes the cost of a full business buyout by summing the value of shares and liabilities minus liquidity, allowing an investor to objectively assess the company's real price and avoid purchasing overvalued assets.

Competing companies

BSX - Full Business Value|EW: Real Price to Acquire Entire Company|RMD - Real Price to Acquire Entire Company|Enterprise Value Insulet Corporation|ZBH (Zimmer Biomet Holdings) - Business Value|COO: Total Company Value|Company Buyout Price ALGN|GMED - Total Company Value|Full Business Value TransMedics Group Inc (TMDX)|ATEC: Enterprise Value|Total Enterprise Value artivion.com AORT|ENOV: Enterprise Value|IART - Real Price to Acquire Entire Company|Motiva - Enterprise Value|iLet Bionic Pancreas (BBNX) - Company Buyout Price|IRMD (IRADIMED CORPORATION) - Enterprise Value|Enterprise Value EMBC|Total Company Value Tandem Diabetes Care, Inc. (TNDM)|Total Company Value AxoGen Inc (AXGN)|Enterprise Value SIBN|OFIX - Company Buyout Price|Real Price to Acquire Entire Company Bioventus Inc.|KIDS - Full Business Value|Enterprise Value TMCI|Blade Air Mobility (SRTA) - Total Enterprise Value|Enterprise Value Carlsmed Corp (CARL)|Business Value RxSight Ophthalmic (RXST)|ClearPoint Neuro, Inc. (CLPT) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash STXS (stereotaxis.com)|Neuronetics - Total Company Value|Real Price to Acquire Entire Company Sight Sciences Inc. SGHT|OBIO (Orchestra BioMed, Inc.) - Enterprise Value|ANIK - Total Enterprise Value|Enterprise Value InspireMD, Inc.|Jin Medical (ZJYL) - Business Value|VANI: Enterprise Value|Company Buyout Price Xtant Medical Inc|Enterprise Value NMTC (NeuroOne Corp)|Real Price to Acquire Entire Company modular-medical.com (MODD)|Enterprise Value MYO (Myomo, Inc.)|envoymedical.com - Enterprise Value|VVOS - Total Company Value|enVVeno Medical Corporation (NVNO) - Total Company Value|Real Price to Acquire Entire Company sintx.com SINT|Tenon Medical Inc (TNON) - Value Adjusted for Debt and Cash|Enterprise Value AMIX (Autonomix Medical Inc.)|Total Enterprise Value IVF|BBLG: Total Company Value|Full Takeover Company Value Axonics Inc. AXNX|Real Price to Acquire Entire Company BIOL (Biolase, Inc.)|Enterprise Value Dynatronics Corp DYNT|Enterprise Value FNA (Paragon 28 Corp)|INVO: Company Buyout Price